Financial Snapshot

Revenue
$3.928M
TTM
Gross Margin
61.41%
TTM
Net Earnings
$1.301M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
257.98%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$4.366M
Q3 2024
Cash
Q3 2024
P/E
607.2
Nov 14, 2024 EST
Free Cash Flow
-$315.5K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2019 2018 2014 2013 2012
Revenue $6.366M $1.133M $69.00K $123.4K $0.00 $0.00 $2.383M $2.670M $3.482M
YoY Change 461.81% 1542.24% -44.1% -10.74% -23.32%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2019 2018 2014 2013 2012
Revenue $6.366M $1.133M $69.00K $123.4K $0.00 $0.00 $2.383M $2.670M $3.482M
Cost Of Revenue $3.913M $716.8K $69.00K $123.1K $1.182M $1.300M $1.849M
Gross Profit $2.453M $416.4K $0.00 $390.00 $1.201M $1.370M $1.632M
Gross Profit Margin 38.54% 36.75% 0.0% 0.32% 50.41% 51.31% 46.88%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2019 2018 2014 2013 2012
Selling, General & Admin $652.8K $374.1K $377.0K $314.9K $437.7K $60.51K $1.561M $1.584M $1.835M
YoY Change 74.49% -0.76% 19.73% 623.3% -1.51% -13.64%
% of Gross Profit 26.61% 89.85% 80735.9% 129.9% 115.66% 112.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.62K $8.075K $0.00 $340.00 $290.00 $290.00 $90.47K $95.83K $125.1K
YoY Change 341.14% -100.0% 0.0% -5.59% -23.4%
% of Gross Profit 1.45% 1.94% 87.18% 7.53% 7.0% 7.66%
Operating Expenses $652.8K $374.1K $378.0K $314.9K $440.2K $60.51K $1.561M $1.584M $1.835M
YoY Change 74.49% -1.02% 20.05% 627.43% -1.51% -13.64%
Operating Profit $1.801M $42.25K -$378.0K -$314.5K -$359.2K -$214.5K -$202.5K
YoY Change 4161.41% -111.18% 20.2% 67.45% 5.94%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2019 2018 2014 2013 2012
Interest Expense -$950.00 -$1.200K $1.000K -$230.00 -$27.07K -$2.260K -$13.79K -$9.150K -$2.020K
YoY Change -20.83% -220.0% -534.78% 1097.79% 50.71% 352.97%
% of Operating Profit -0.05% -2.84%
Other Income/Expense, Net $73.01K $2.297K $7.000K $0.00 $1.400K $710.00 $6.750K $22.45K
YoY Change 3078.32% -100.0% -89.48% -69.93%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2019 2018 2014 2013 2012
Pretax Income $1.874M $44.55K -$378.0K -$307.7K -$467.2K -$61.36K -$372.3K -$216.9K -$182.1K
YoY Change 4105.57% -111.79% 22.85% 661.46% 71.63% 19.15%
Income Tax $309.0K $0.00 $0.00 $0.00
% Of Pretax Income 16.49%
Net Earnings $1.565M $44.55K -$378.0K -$307.7K -$467.2K -$61.36K -$372.3K -$216.9K -$182.1K
YoY Change 3411.87% -111.79% 22.85% 661.46% 71.63% 19.15%
Net Earnings / Revenue 24.58% 3.93% -547.83% -249.27% -15.62% -8.13% -5.23%
Basic Earnings Per Share $0.01 $0.01
Diluted Earnings Per Share $0.01 $0.01 -$512.9K -$5.556M -$27.31M -$3.590M -$41.23M -$25.70M -$22.90M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2019 2018 2014 2013 2012
Cash & Short-Term Investments $5.158M $2.718M $70.00K $35.61K $1.560K $76.29K $190.4K $388.9K $403.2K
YoY Change 89.8% 3782.5% 96.57% -97.96% -51.05% -3.55%
Cash & Equivalents $5.158M $2.718M $70.00K $35.61K $1.560K $76.29K
Short-Term Investments
Other Short-Term Assets $103.4K $18.86K $77.00K $113.2K $0.00 $11.83K $163.9K $78.61K $41.59K
YoY Change 448.25% -75.51% -31.98% -100.0% 108.5% 89.01%
Inventory $148.6K $138.1K $146.3K
Prepaid Expenses
Receivables $183.6K $291.9K $2.000K $2.250K $12.48K $17.71K $22.29K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $5.445M $3.029M $149.0K $151.1K $1.560K $88.12K $515.3K $623.3K $613.4K
YoY Change 79.8% 1932.55% -1.36% -98.23% -17.32% 1.62%
Property, Plant & Equipment $271.5K $93.81K $117.0K $0.00 $620.00 $900.00 $172.7K $404.5K $332.2K
YoY Change 189.38% -19.82% -31.11% -57.3% 21.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $59.58K $27.72K $5.000K $0.00 $6.670K
YoY Change 114.94% 454.4% -100.0%
Total Long-Term Assets $331.1K $121.5K $122.0K $0.00 $610.00 $900.00 $172.7K $404.5K $338.9K
YoY Change 172.4% -0.39% -32.22% -57.3% 19.36%
Total Assets $5.776M $3.150M $271.0K $151.1K $2.170K $89.02K $688.0K $1.028M $952.2K
YoY Change
Accounts Payable $566.8K $222.8K $15.00K $5.060K $0.00 $58.71K $214.7K $150.6K
YoY Change 154.45% 1385.0% 196.44% -72.65% 42.53%
Accrued Expenses $109.6K $29.39K $37.55K $33.00K $17.50K $161.6K $155.1K $123.6K
YoY Change 272.78% -21.73% 88.57% 4.18% 25.42%
Deferred Revenue
YoY Change
Short-Term Debt $1.283M $1.047M $818.7K $556.5K $288.7K $117.2K $110.1K $105.6K $101.1K
YoY Change 22.55% 27.9% 47.11% 146.35% 4.25% 4.45%
Long-Term Debt Due $38.00K $100.1K $29.13K $5.830K
YoY Change 243.73% 399.66%
Total Short-Term Liabilities $2.269M $1.299M $871.0K $561.6K $321.7K $134.7K $1.300M $1.524M $1.418M
YoY Change 74.61% 49.17% 55.11% 138.84% -14.67% 7.45%
Long-Term Debt $0.00 $0.00 $74.00K $0.00 $0.00 $0.00 $0.00 $99.18K $12.38K
YoY Change -100.0% -100.0% 701.13%
Other Long-Term Liabilities $89.73K $44.41K $73.80K
YoY Change 102.05% -39.82%
Total Long-Term Liabilities $89.73K $44.41K $74.00K $0.00 $0.00 $0.00 $0.00 $99.18K $12.38K
YoY Change 102.05% -39.99% -100.0% 701.13%
Total Liabilities $2.358M $1.344M $945.0K $561.6K $321.7K $134.7K $1.300M $1.623M $1.430M
YoY Change 75.52% 42.19% 68.28% 138.84% -19.89% 13.45%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2019 2018 2014 2013 2012
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $790.14 Million

About QDM International Inc.

QDM International Inc is a HK-based company operating in Insurance industry. The company employs 5 full-time employees The company went IPO on 2000-06-22. QDM International Inc, formerly 24/7 Kid Doc Inc, is a telemedicine company that offers telemedicine access to K-12 schools at no cost to those schools and bill the patient’s insurance or Medicaid for the consultation. The firm provides Connect-a-Doc telemedicine kits to schools. The telemedicine kits generally include digital otoscope, stethoscope, blood pressure cuff, dental camera and dermatology camera. The firm provides services which include acute illness or injury care, dermatology examinations of rashes and lesions, diagnosis and recommendations as to treatment or referral, administering scheduled medications, prescribing non-narcotic medications via e-prescription directly to the student’s designated pharmacy, mental health counseling for depression, drug abuse, and family problems and consulting with staff regarding eating disorders and other behavior issues.

Industry: Insurance Agents, Brokers & Service Peers: Aesthetic Medical International Holdings Group Ltd Concord Medical Services Holdings Ltd